Inventor
SCHIFFER-MANNIOUI CÉCILE
FR9 patents
Patents
9 patentsUS10874693B2Dec 29, 2020
CD19 specific chimeric antigen receptor and uses thereof
CELLECTIS7 citations92
US11077144B2Aug 3, 2021
CD19 specific chimeric antigen receptor and uses thereof
CELLECTIS7 citations83
US10752684B2Aug 25, 2020
ROR1 (NTRKR1) specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS12 citations83
US10759868B2Sep 1, 2020
Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS6 citations82
US11304975B2Apr 19, 2022
Methods for engineering allogeneic and highly active t cell for immunotherapy
CELLECTIS4 citations72
US11311575B2Apr 26, 2022
Methods for engineering highly active T cell for immunotherapy
CELLECTIS1 citations62
US11007224B2May 18, 2021
CD19 specific chimeric antigen receptor and uses thereof
CELLECTIS0 citations62
US10544201B2Jan 28, 2020
ROR1 specific multi-chain chimeric antigen receptor
CELLECTIS1 citations60
US10752670B2Aug 25, 2020
Anti-GD3 specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS0 citations51